recent
event
surround
emerg
infecti
diseas
bioterror
increas
multidrug
antibiot
resist
bacteria
drastic
increas
current
need
effect
vaccin
mani
year
studi
shown
live
attenu
pathogen
often
effect
deliv
heterolog
protein
dna
induc
protect
immun
respons
howev
vaccin
carrier
inher
safeti
concern
limit
develop
use
mani
patient
popul
studi
use
nonliv
deliveri
mechan
shown
provid
protein
antigen
dna
encod
antigen
individu
induc
improv
protect
immun
respons
rare
ever
deliv
simultan
nonrepl
bacteri
minicel
deriv
commens
e
coli
strain
shown
effect
induc
antigenspecif
immun
respons
simultan
protein
dna
deliveri
data
demonstr
potenti
use
achromosom
bacteri
minicel
vaccin
carrier
grow
concern
realiti
multidrug
resist
pathogen
strain
bacteria
alarm
rate
emerg
infecti
diseas
sar
sever
acut
respiratori
syndrom
viru
lyme
diseas
avian
flu
viru
strain
stimul
scientif
commun
discov
novel
vaccin
vaccin
carrier
recent
use
bacillu
anthraci
anthrax
agent
bioterror
unit
state
also
help
acceler
nation
interest
vaccin
develop
discoveri
protect
antigen
remain
critic
tool
vaccin
develop
research
effort
design
test
differ
deliveri
mechan
vaccin
formul
overal
efficaci
also
need
studi
aspect
vaccin
develop
becom
increasingli
clear
induct
humor
immun
via
parenter
administr
case
suffici
protect
best
rout
vaccin
administr
via
mucos
surfac
especi
protect
organ
use
surfac
site
entri
effici
deliveri
concern
approach
howev
studi
util
genet
engin
attenu
pathogen
bacteria
virus
vaccin
carrier
shown
promis
multitud
differ
infect
tumor
model
although
carrier
demonstr
efficaci
anim
model
administr
human
limit
safeti
concern
rang
gener
advers
inflammatori
respons
threat
revers
pathogen
state
result
horizont
gene
transfer
caus
cancer
demonstr
case
viral
vector
one
potenti
strategi
develop
nonliv
nonattenu
vaccin
carrier
use
bacteri
minicel
bacteri
minicel
small
nondivid
achromosom
nm
vesicl
produc
bacteri
speci
result
prematur
septat
studi
focus
properti
e
coli
minicel
shown
minicel
engin
packag
plasmid
dna
recombin
protein
biochem
level
minicel
shown
metabol
activ
activ
transport
metabolit
transcrib
translat
plasmid
encod
gene
product
subject
infect
bacteriophag
addit
minicel
contain
structur
protein
lipid
constitu
parent
cell
includ
lipopolysaccharid
lp
lysophosphatid
acid
lpa
intact
peptidoglycan
layer
surfac
compon
quickli
recogn
antigen
present
cell
apc
pathogen
associ
molecular
pattern
tolllik
receptor
express
cell
interact
lp
particular
help
stimul
inflammatori
respons
necessari
gener
immun
respons
well
promot
uptak
process
bacteria
minicel
retain
abil
parent
bacteri
cell
work
bacteri
minicel
deriv
commens
e
coli
strain
use
deliv
protein
antigen
andor
plasmid
dna
elicit
antigenspecif
immun
respons
mice
use
green
fluoresc
protein
gfp
gener
antigen
monitor
antibodi
product
sera
well
mucosa
best
minicel
formul
test
contain
recombinantli
express
antigen
well
plasmid
dna
encod
antigen
eukaryot
control
deliveri
combin
abl
induc
high
level
igg
sera
introduct
sever
differ
rout
includ
intramuscular
im
intranas
oral
po
administr
taken
togeth
result
suggest
develop
minicel
could
suitabl
safe
effect
vaccin
deliveri
vehicl
minicel
produc
e
coli
strain
f
ilvg
zac
aph
laci
q
p
tac
phoa
obtain
vaxiion
therapeut
inc
wild
type
ftsz
strain
replac
ftsz
control
tac
promot
requir
addit
iptg
support
normal
divis
growth
induct
minicel
phenotyp
requir
addit
iptg
ad
media
describ
strain
harbor
gfp
pgfpvax
streak
glycerol
stock
lb
agar
contain
iptg
gml
kanamycin
gml
ampicillin
grown
c
overnight
cultur
grown
ml
lb
broth
contain
iptg
gml
kanamycin
gml
ampicillin
appropri
shake
c
e
coli
cell
harbor
plasmid
grown
lb
agar
contain
gml
ampicillin
c
overnight
cultur
start
isol
coloni
grown
ml
lb
broth
contain
gml
ampicillin
lbamp
plasmid
use
studi
summar
tabl
rhamnos
induc
bacteri
express
vector
gfp
obtain
mpex
pharmaceut
inc
describ
elsewher
plasmid
construct
subclon
codon
optim
gfp
express
cassett
pgreen
lantern
uniqu
hindiii
site
hindiii
site
introduc
gfp
cassett
pcr
prior
subclon
posit
clone
identifi
abil
express
gfp
cultur
cell
follow
lipofectamin
tm
mediat
transfect
plasmid
pgfpvax
gener
subclon
eukaryot
express
cassett
drive
gfp
describ
uniqu
hindiii
site
gfp
posit
clone
select
abil
express
gfp
cell
upon
induct
rhamnos
well
abil
express
gfp
cultur
cell
follow
transfect
lipofectamin
tm
strain
harbor
plasmid
describ
grown
overnight
describ
subcultur
ml
lb
broth
contain
iptg
gml
kanamycin
gml
ampicillin
cultur
allow
grow
optic
densiti
nm
cell
contain
induc
produc
minicel
addit
iptg
final
concentr
cell
harbor
gfp
pgfpvax
coinduc
simultan
produc
minicel
gfp
protein
addit
iptg
lrhamnos
final
concentr
mm
respect
cultur
grown
overnight
h
time
induct
two
hour
harvest
minicel
ciproflaxin
ad
cultur
final
concentr
gml
reduc
number
viabl
contamin
parent
cell
prior
immun
minicel
harvest
differenti
centrifug
linear
sucros
gradient
describ
use
lb
broth
buffer
oppos
bsg
quantif
carri
read
purifi
sampl
appli
equat
minicellsml
approxim
minicel
serial
dilut
plate
determin
puriti
function
number
viabl
coloni
per
minicel
standard
western
blot
techniqu
use
quantit
determin
rel
amount
gfp
protein
minicel
primari
antibodi
use
mous
monoclon
igg
gfp
abcam
cambridg
dilut
pb
contain
tween
pbst
blot
incub
primari
antibodi
h
room
temperatur
follow
three
wash
pbst
hrpconjug
goat
monoclon
igg
antimous
antibodi
sigma
st
loui
mo
use
dilut
pbst
secondari
antibodi
follow
three
wash
pbst
blot
develop
use
western
ecl
kit
perkinelm
boston
murin
macrophag
raw
murin
macrophag
cultur
invitrogen
carlsbad
ca
contain
penicillin
streptomycin
penstrep
supplement
fetal
bovin
serum
c
co
atmospher
raw
cell
line
obtain
american
type
cultur
collect
atcc
rockford
maryland
bone
marrow
deriv
macrophag
bmdm
dendrit
cell
bmddc
isol
differenti
describ
use
gml
macrophag
coloni
stimul
factor
mcsf
granulocyt
macrophag
stimul
factor
gmcsf
ex
vivo
product
macrophag
dendrit
cell
respect
raw
bmdm
bmddc
seed
densiti
tissu
cultur
treat
fourwel
slide
chamber
bd
bioscienc
bedford
ml
describ
media
cell
allow
h
adher
minicel
ad
purifi
minicel
contain
plasmid
stain
min
sybr
gold
molecular
probe
inc
carlsbad
ca
final
concentr
gml
sybr
goldstain
minicel
ad
directli
media
allow
incub
min
cell
immedi
wash
three
time
ml
pb
remov
remain
minicel
fix
ml
paraformaldehyd
pb
min
c
visual
confoc
microscopi
purifi
minicel
contain
plasmid
ad
raw
bmdm
bmddc
cultur
fourwel
slide
chamber
differ
multipl
infect
moi
allow
incub
h
c
co
atmospher
follow
incub
minicel
remov
cell
wash
three
time
steril
pb
ensur
kill
remain
extracellular
bacteria
cell
cultur
l
media
contain
gml
gentamycin
allow
incub
c
co
h
h
media
remov
replac
ml
contain
penstrep
fb
allow
incub
h
allow
transgen
express
h
cell
fix
analyz
gfp
express
confoc
microscopi
e
coli
cell
contain
cultur
describ
follow
day
subcultur
ml
lbamp
perform
cell
allow
grow
midlog
phase
induct
histag
gfp
express
iptg
cultur
allow
grow
overnight
shake
c
histag
gfp
purifi
use
qiagen
nickelnta
quick
elut
spin
kit
describ
manufactur
qiagen
inc
valencia
ca
purifi
gfp
dialyz
pb
overnight
slide
dialyz
kda
molecular
weight
cutoff
pierc
rockford
il
protein
concentr
determin
bradford
assay
sigma
use
standard
curv
gener
known
concentr
bsa
puriti
determin
coomasi
stain
sdspage
gel
data
shown
intramuscular
im
immun
group
six
femal
mice
week
age
immun
right
quadricep
pb
contain
nake
plasmid
dna
pgfpvax
minicel
contain
empti
vector
plasmid
minicel
contain
solubl
gfp
protein
gfp
minicel
contain
eukaryot
express
cassett
drive
gfp
express
minicel
contain
solubl
gfp
protein
plasmid
contain
eukaryot
gfp
cassett
pgfpvax
l
volum
pb
total
minicel
use
individu
immun
mucos
immun
nasal
administ
mucos
immun
carri
administr
minicel
l
volum
via
pipetman
l
per
nostril
mice
anesthet
isoflouran
gastric
po
immun
mice
anesthet
isoflouran
given
minicel
l
volum
sodium
bicarbon
buffer
ph
feed
cannula
total
minicel
use
individu
immun
immun
three
dose
regimen
took
place
day
mice
sacrif
day
immun
singl
dose
regimen
took
place
day
mice
sacrif
day
mice
sacrif
administr
co
blood
harvest
immedi
cardiac
punctur
isol
sera
blood
allow
clot
h
room
temperatur
c
overnight
follow
day
blood
clot
remov
result
sera
purifi
min
centrifug
g
remov
contamin
red
blood
cell
lymphocyt
sera
frozen
c
subsequ
analysi
isol
iga
lung
trachea
euthan
mice
expos
tracheal
tube
nick
scissor
lung
wash
ml
pb
contain
mm
pmsf
mm
edta
pbspe
tuberculin
syring
fit
mm
blunt
end
lurlock
accessori
secur
trachea
sutur
collect
volum
subject
min
spin
g
remov
cell
cellular
debri
lung
lavag
fluid
store
c
prior
analysi
isol
iga
small
intestin
cm
section
small
intestin
remov
euthan
mice
flush
ml
pbspe
sampl
centrifug
min
g
remov
cellular
debri
supernat
remov
iga
precipit
concentr
addit
vv
satur
ammonium
sulfat
c
precipit
centrifug
g
min
supernat
discard
result
pellet
resuspend
ml
pbspe
dialyz
h
result
intestin
lavag
store
c
prior
analysi
sera
immun
mice
analyz
enzymelink
immunosorb
assay
elisa
presenc
gfp
specif
igg
purifi
recombin
gfp
use
coat
microtit
plate
gwell
overnight
c
sera
serial
dilut
plate
allow
incub
h
room
temperatur
dilut
hrpconjug
goat
monoclon
antimous
igg
pbst
serv
secondari
antibodi
detect
perform
use
hrp
substrat
tmb
lwell
pierc
reaction
allow
proceed
color
develop
well
stop
addit
l
h
plate
read
nm
od
serum
titer
igg
calcul
averag
od
valu
serum
dilut
individu
mice
two
independ
experi
n
total
six
mice
per
group
valu
plot
serum
dilut
valu
obtain
half
maxim
od
read
calcul
divid
highest
od
individu
group
titer
defin
reciproc
averag
dilut
factor
requir
achiev
half
maximum
signal
nm
plot
averag
titer
valu
group
subtract
background
fig
lung
intestin
lavag
assay
elisa
exactli
describ
sera
except
secondari
antibodi
use
goat
antimous
iga
conjug
hrp
sigma
result
iga
detect
experi
express
averag
increas
absorb
read
dilut
lavag
fluid
fig
data
present
mean
sem
statist
signific
differ
experiment
group
calcul
oneway
anova
unpair
student
ttest
use
graphpad
prism
version
softwar
major
goal
studi
present
demonstr
minicel
produc
e
coli
strain
util
produc
vaccin
capabl
encapsul
heterolog
protein
antigen
well
eukaryot
express
plasmid
deliveri
vivo
end
cell
harbor
plasmid
gfp
induc
produc
gfp
simultan
minicel
product
fig
show
minicel
purifi
describ
section
found
contain
detect
level
gfp
protein
use
confoc
microscopi
quantif
gfp
protein
perform
use
seri
western
blot
shown
deriv
minicel
prepar
conjunct
densitometri
result
shown
fig
demonstr
minicel
could
also
encapsul
plasmid
dna
plasmid
dna
isol
minicel
deriv
harbor
either
gfp
pgfpvax
plasmid
amount
recov
plasmid
dna
quantit
use
read
summari
formul
result
plasmid
also
shown
fig
data
show
minicel
either
encapsul
plasmid
dna
alon
combin
express
recombin
protein
prior
immun
import
reduc
number
viabl
parent
cell
remain
minicel
prepar
end
minicellproduc
cultur
treat
gml
ciproflaxin
prior
isol
minicel
determin
number
viabl
contamin
parent
cell
reduc
minicel
minicel
cultur
treat
ciproflaxin
h
major
mechan
vaccin
action
elicit
protect
immun
respons
deliv
antigen
apc
present
lymphocyt
test
whether
minicel
potenti
deliv
heterolog
protein
apc
vivo
uptak
minicel
evalu
sever
differ
immunolog
relev
phagocyt
cell
line
vitro
minicel
harbor
plasmid
dna
stain
sybr
gold
uptak
follow
variou
time
point
shown
fig
substanti
number
minicel
taken
cell
min
cell
line
test
includ
raw
bmdm
bmddc
exhibit
abil
phagocytos
minicel
similar
kinet
addit
control
ident
experi
perform
hela
cell
hela
cell
nonphagocyt
normal
condit
result
minicel
uptak
seen
time
point
observ
cell
line
data
shown
uptak
minicel
apc
cultur
support
hypothesi
minicel
deliv
heterolog
protein
directli
apc
present
immun
cell
minicel
uptak
cultur
apc
demonstr
evalu
abil
minicel
deliv
dna
subsequ
express
vitro
accordingli
minicel
harbor
eukaryot
gfp
report
construct
see
tabl
incub
cultur
apc
variou
moi
h
fig
show
bmddc
express
gfp
transgen
deliv
bacteri
minicel
cultur
raw
bmdm
bmddc
show
similar
express
pattern
data
shown
counterstain
apc
dapi
allow
quantif
percent
cell
transfect
found
depend
cell
type
use
raw
cell
highest
number
transfect
like
mitot
activ
rapidli
divid
cell
easili
transfect
observ
demonstr
transfect
effici
high
cell
vitro
minicel
abil
deliv
dna
protein
express
apc
case
attenu
bacteri
strain
use
genet
vaccin
carrier
transfect
effici
vitro
correl
well
seen
vivo
requir
vivo
studi
true
test
vaccin
deliveri
efficaci
test
antigenspecif
immun
respons
gfp
mice
immun
three
time
via
im
rout
sever
differ
minicel
formul
minicel
use
includ
encapsul
either
gfp
protein
alon
eukaryot
express
plasmid
dna
alon
combin
gfp
protein
plasmid
dna
minicel
empti
vector
control
comparison
nake
plasmid
dna
administ
amount
equival
encapsul
minicel
g
dna
immun
schedul
seen
fig
increas
antibodi
titer
mice
immun
minicel
contain
heterolog
gfp
protein
antigen
plasmid
encod
mammalian
express
cassett
drive
gfp
express
mc
dnaprotein
increas
serum
titer
gfpspecif
igg
mice
immun
nake
plasmid
dna
alon
minicel
contain
gfp
protein
antigen
alon
minicel
contain
plasmid
dna
vaccin
alon
result
indic
much
higher
antibodi
respons
achiev
recombinantli
express
protein
antigen
eukaryot
express
plasmid
dna
deliv
togeth
minicel
vehicl
mice
mice
immun
empti
vector
minicel
neg
gfpspecif
antibodi
mani
vaccin
requir
multipl
dose
desir
develop
vaccin
deliveri
mechan
requir
singl
administr
elicit
strong
immun
respons
determin
gfpspecif
immun
respons
could
also
achiev
singl
dose
minicel
mice
subsequ
immun
singl
im
administr
use
minicel
formul
use
sera
harvest
mice
day
reveal
gfpspecif
igg
antibodi
detect
follow
singl
dose
fig
although
titer
observ
iden
control
group
immun
time
im
either
plasmid
dna
nake
dna
serum
harvest
day
gfpspecif
igg
antibodi
detect
elisa
b
gfpspecif
igg
sera
detect
singl
dose
administr
mice
immun
one
time
im
describ
gfpspecif
antibodi
detect
elisa
day
titer
experi
calcul
describ
section
p
compar
group
p
compar
group
test
tical
observ
tripl
dose
immun
schedul
experi
dna
alon
either
nake
encapsul
minicel
effici
shown
fig
nevertheless
minicel
contain
heterolog
gfp
protein
antigen
plasmid
encod
antigen
induc
signific
p
increas
gfpspecif
antibodi
titer
produc
nake
plasmid
dna
alon
minicel
contain
protein
dna
alon
effici
induc
humor
immun
respons
provid
support
hypothesi
abil
minicel
simultan
deliv
dna
protein
may
benefici
develop
vaccin
clinic
use
studi
shown
fig
also
indic
multipl
dose
deliv
im
may
result
signific
increas
titer
observ
singl
dose
minicel
deliv
dna
protein
oppos
either
alon
use
minicel
vaccin
test
abil
elicit
immun
respons
mucos
deliveri
mice
immun
three
time
minicel
contain
recombin
gfp
protein
plasmid
dna
encod
eukaryot
gfp
express
cassett
pgfpvax
im
po
rout
minicel
type
test
experi
abil
induc
higher
immun
respons
im
administr
see
fig
result
illustr
fig
indic
mice
immun
minicel
test
rout
gener
gfpspecif
igg
antibodi
titer
serum
intramuscular
deliveri
show
increas
gfpspecif
antibodi
titer
sera
harvest
mice
immun
either
intranas
oral
rout
expect
mice
show
respons
data
indic
bacteri
minicel
could
stimul
format
system
immun
respons
mucos
deliveri
mucos
immun
confer
protect
pathogen
typic
induc
presenc
antigenspecif
iga
mucos
line
gfpspecif
iga
content
mice
immun
variou
rout
compar
fig
show
detect
amount
iga
found
lung
mice
immun
rout
lung
lavag
mice
immun
po
im
fig
illustr
detect
gfpspecif
iga
intestin
lavag
fluid
mice
immun
po
rout
immun
rout
administr
although
amount
produc
low
data
indic
minicel
potenti
induc
iga
product
expect
site
mucos
immun
present
work
demonstr
bacteri
minicel
deriv
commens
e
coli
strain
gener
antigen
specif
immun
respons
mice
minicel
capabl
simultan
deliv
recombinantli
express
heterolog
gfp
protein
antigen
plasmidbas
gfp
dna
eukaryot
express
cassett
induc
greatest
respons
everi
condit
test
robust
igg
respons
record
follow
singl
im
inject
could
increas
somewhat
util
three
dose
regimen
advers
effect
inflamm
infect
observ
site
inject
mice
immun
im
suggest
mice
abl
toler
amount
lp
present
surfac
minicel
also
found
minicel
deliv
heterolog
protein
dna
encod
antigen
eukaryot
control
could
induc
antigenspecif
igg
antibodi
respons
sera
low
detect
gfpspecif
iga
mucos
lavag
fluid
three
dose
regimen
administ
either
po
rout
data
demonstr
potenti
bacteri
minicel
carrier
protein
andor
dna
gener
protect
mucos
administ
vaccin
develop
nonliv
nonattenu
deliveri
system
major
implic
vaccin
develop
potenti
deliv
vaccin
immunecompromis
individu
elderli
children
year
age
sever
potenti
advantag
use
minicel
deriv
commens
e
coli
strain
bacteria
fit
unmet
need
minicel
deriv
commens
bacteria
like
better
toler
heatkil
vaccin
deriv
pathogen
bacteria
potenti
reduc
advers
inflammatori
immun
respons
beyond
safeti
advantag
anoth
potenti
advantag
stem
versatil
natur
minicel
carrier
implement
differ
primeboost
strategi
use
differ
vaccin
modal
sequenti
deliveri
genet
vaccin
protein
antigen
shown
effect
induc
humor
respons
human
genet
vaccin
alon
well
facilit
minicel
deliveri
system
strategi
proven
effect
use
polioviru
replicon
attenu
salmonella
enterica
sv
typhi
sever
genet
immun
protocol
case
immun
system
prime
genet
vaccin
boost
correspond
recombin
antigen
anoth
potenti
advantag
use
e
coli
minicel
deliv
protein
antigen
dna
e
coli
normal
part
microflora
gut
minicel
deriv
strain
abil
surviv
hostil
environ
gastrointestin
tract
make
attract
candid
mucos
deliveri
hand
use
minicel
deriv
commens
bacteria
may
disadvantag
preexist
natur
mucos
toler
built
minicel
vector
result
exposur
immun
system
commens
bacteri
antigen
vaccin
platform
adjuv
properti
vehicl
may
import
gener
immun
respons
enhanc
immunogenec
ie
foreign
may
requir
effici
vaccin
deliveri
howev
immunogen
vehicl
may
also
prevent
subsequ
use
vehicl
deliv
differ
vaccin
memori
respons
vehicl
rais
first
immun
shown
case
salmonella
sp
use
carrier
test
requir
fulli
evalu
abil
commens
e
coli
minicel
effect
deliv
antigen
dna
use
mucos
rout
administr
time
mucos
immun
understood
nearli
well
humor
immun
especi
respect
develop
immunolog
memori
inform
becom
avail
mechan
requir
establish
immunolog
memori
mucosa
improv
need
enhanc
efficaci
minicel
vaccin
carrier
better
understood
data
shown
directli
demonstr
minicel
induc
immun
respons
deliveri
heterolog
protein
antigen
dna
encod
antigen
mani
question
remain
exampl
studi
shown
strongli
suggest
multipl
immun
superior
minicel
deliv
dna
protein
may
dna
compon
prime
anim
respond
subsequ
exposur
protein
vice
versa
hand
singl
dose
administr
nake
dna
alon
minicel
contain
plasmid
dna
gave
higher
specif
antibodi
titer
compar
mice
immun
three
time
see
fig
possibl
due
time
test
day
singl
administr
versu
day
immun
experiment
requir
determin
case
either
way
result
suggest
boost
necessarili
effect
increas
antigen
specif
serum
igg
level
nake
dna
minicel
encapsul
dna
use
may
due
effect
vector
prime
shown
certain
salmonella
serovar
use
deliv
vaccin
studi
shown
previou
exposur
relev
salmonella
carrier
result
dramat
decreas
immun
respons
antigen
deliv
later
time
carrier
result
shown
fig
also
suggest
use
minicel
deliv
solubl
protein
antigen
larg
ineffect
may
solubl
gfp
protein
mildli
immunogen
locat
interior
minicel
exchang
gfp
immunogen
cytosol
antigen
like
ltb
express
protein
antigen
surfac
minicel
may
help
increas
antibodi
titer
futur
studi
util
biolog
relev
antigen
requir
elucid
mechan
behind
result
addit
determin
abil
protect
well
longev
isotyp
profil
antibodi
respons
given
minicel
system
engin
produc
antigenspecif
immun
respons
next
logic
step
demonstr
gener
protect
immun
perform
live
pathogen
challeng
experi
mice
ultim
goal
develop
minicel
vaccin
provid
protect
immun
mucos
immun
pathogen
bacteri
viral
origin
